What is a common recommendation for the long-term treatment of chronic anxiety?

The common recommendation for the long-term treatment of chronic anxiety is the use of SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), or Buspirone. These medications are widely used because they are effective in managing anxiety symptoms and have a favorable side effect profile compared to other classes of medications.

SSRIs, such as fluoxetine, sertraline, and escitalopram, work by increasing serotonin levels in the brain, which can help improve mood and decrease anxiety. Similarly, SNRIs like venlafaxine and duloxetine increase both serotonin and norepinephrine levels, offering additional benefit for anxiety management. Buspirone is specifically indicated for anxiety as well and is less sedating than benzodiazepines, making it a suitable option for some patients.

These medications are often preferred for long-term treatment due to their efficacy and lower risk of dependence, which can be a significant concern with other types of medication, particularly benzodiazepines. Thus, SSRIs, SNRIs, or Buspirone represent a well-established approach for treating chronic anxiety over an extended period.